Literature DB >> 11038992

Intermediate and late rheumatoid arthritis treated by tonifying the kidney, resolving phlegm and removing blood stasis.

X Zhou1, Z Zhou, M Jin, H Wang, M Wu, Q Gu, Z Wang, W Shang.   

Abstract

Eighty-seven cases of intermediate and late rheumatoid arthritis were treated with Instant Shu Guan Wen Jing Granules ([symbol: see text] Relaxing Joints by Warming Channels) and Instant Shu Guan Qing Luo Granules ([symbol: see text] Relaxing Joints by Removing Heat from the Lung Channel) to tonify the kidney, resolve phlegm and remove blood stasis, and compared with 41 cases treated with Instant Wang Bi Granules ([symbol: see text] Prescription for Arthralgia-syndrome). The treatment produced a clinical cure rate of 54.0% and a total effective rate of 90.8% as in against 29.3% and 73.2% respectively in the control group. The difference was significant (P < 0.01). Improvement in main symptoms and laboratory findings in the treatment group was all more marked than that in the control group (P < 0.05 or P < 0.01), with no side effects observed.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11038992

Source DB:  PubMed          Journal:  J Tradit Chin Med        ISSN: 0255-2922            Impact factor:   0.848


  3 in total

Review 1.  Chinese medicine pattern diagnosis could lead to innovation in medical sciences.

Authors:  Ai-Ping Lu; Ke-Ji Chen
Journal:  Chin J Integr Med       Date:  2011-11-06       Impact factor: 1.978

Review 2.  Systematic review of the methodological quality of controlled trials evaluating Chinese herbal medicine in patients with rheumatoid arthritis.

Authors:  Xin Pan; Maria A Lopez-Olivo; Juhee Song; Gregory Pratt; Maria E Suarez-Almazor
Journal:  BMJ Open       Date:  2017-03-01       Impact factor: 2.692

3.  Therapeutic Effect of Xuebijing, a Traditional Chinese Medicine Injection, on Rheumatoid Arthritis.

Authors:  Shutong Li; Hongxing Wang; Qinbao Sun; Bin Liu; Xiaotian Chang
Journal:  Evid Based Complement Alternat Med       Date:  2020-01-28       Impact factor: 2.629

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.